Page last updated: 2024-10-28

ifosfamide and Gaucher Disease

ifosfamide has been researched along with Gaucher Disease in 2 studies

Gaucher Disease: An autosomal recessive disorder caused by a deficiency of acid beta-glucosidase (GLUCOSYLCERAMIDASE) leading to intralysosomal accumulation of glycosylceramide mainly in cells of the MONONUCLEAR PHAGOCYTE SYSTEM. The characteristic Gaucher cells, glycosphingolipid-filled HISTIOCYTES, displace normal cells in BONE MARROW and visceral organs causing skeletal deterioration, hepatosplenomegaly, and organ dysfunction. There are several subtypes based on the presence and severity of neurological involvement.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Lucari, B1
Tallis, E1
Sutton, VR1
Porea, T1
Böhm, P1
Kunz, W1
Horny, HP1
Einsele, H1

Reviews

1 review available for ifosfamide and Gaucher Disease

ArticleYear
Adult Gaucher disease in association with primary malignant bone tumors.
    Cancer, 2001, Feb-01, Volume: 91, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide;

2001

Other Studies

1 other study available for ifosfamide and Gaucher Disease

ArticleYear
Dual enzyme therapy improves adherence to chemotherapy in a patient with gaucher disease and Ewing sarcoma.
    Pediatric hematology and oncology, 2023, Volume: 40, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Cyclophosphamide;

2023